Plain-English translation of NCT07312305 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is looking at a specific part of the lungs called small airways in people who have just been diagnosed with idiopathic pulmonary fibrosis (IPF), a serious lung disease where lung tissue becomes scarred and stiff over time. Researchers will use a special breathing test called a nitrogen washout test to measure how well these small airways are working before you start treatment and then again after one year of taking antifibrotic medication (the medication your doctor prescribes to slow the disease). The goal is to understand how common small airway problems are in IPF and whether the medication helps improve this.
Most research on IPF focuses on the larger lung structures, but doctors don't know how often small airways are damaged in newly diagnosed patients or how well current treatments help them. This study aims to fill that gap so doctors can better understand and potentially monitor all the ways IPF affects your lungs.
You likely qualify if…
You likely don't qualify if…
You will visit the research clinic at enrollment to have breathing tests, clinical assessments, and imaging scans (like a chest CT scan if recent). The key test is a special breathing test that measures how your small airways are working. You will then start or continue your antifibrotic medication as prescribed by your doctor. After one year, you will return for repeat breathing tests and assessments to see if the medication has changed how your small airways function. The study involves outpatient visits only — no hospital stays or experimental drugs are involved.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Italy